Matthew Schellenberg

9PUBLICATIONS

53CO-AUTHORS

Haematological tumoursProteins and peptidesMolecular targetsBiomaterialsQuality assurance, chemometrics, traceability and metrological chemistry

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (9)

Sort by Publication Date:

|Jul 23, 2026

Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC derived cardiomyocytes.

|May 21, 2026

Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ.

|May 27, 2025

Topobexin targets the Topoisomerase II ATPase domain for beta isoform-selective inhibition and anthracycline cardioprotection.

Jan Kubeš, Galina Karabanovich, Anh T Q Cong

|Mar 07, 2024

Dimerization-dependent serine protease activity of FAM111A prevents replication fork stalling at topoisomerase 1 cleavage complexes.

Sowmiya Palani, Yuka Machida, Julia R Alvey

|Dec 19, 2023

Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer.

Swaathi Jayaraman, Xinyan Wu, Krishna R Kalari

|Dec 14, 2023

ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes.

Heeyoun Bunch, Deukyeong Kim, Masahiro Naganuma

Pageof 2

Frequent Collaborators

Anh T Q Cong

Julia R Alvey

Taylor L Witter

Matthew P Goetz

Caroline Austin

Jan Kubeš

Akhilesh Pandey

Jasmina Paluncic

R Scott Williams

John R Hawse

Frequent Collaborators

Anh T Q Cong

Julia R Alvey

Taylor L Witter

Matthew P Goetz